GN Store Nord
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 h
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed explanation of how the transition plan for climate change mitigation is integrated into and aligned with your company's overall business strategy and financial planning.
-
Question Id: E1-1_13
Moreover, our climate reduction initiatives as described on these pages, are anchored within our existing business model and financial planning. This is further supported by the fact that we do not currently have material climate-related financial risks (see page 29), and the fact that GN is not excluded from the Paris-aligned benchmarks.
Report Date: 4Q2024Relevance: 60%
- Provide a detailed disclosure of biogenic emissions of CO2 resulting from the combustion or biodegradation of biomass, ensuring these are reported separately from Scope 2 GHG emissions. Include emissions of other greenhouse gases, specifically CH4 and N2O, within this disclosure. If the emission factors utilized do not distinctly identify the percentage of biomass or biogenic CO2, disclose this information. Additionally, if emissions of GHGs other than CO2, particularly CH4 and N2O, are unavailable or excluded from location-based grid average emissions factors or the market-based method, disclose this information accordingly.
-
Question Id: E1-6_24
Biogenic CO2 emissions in Scope 1 are reported as 0.13. Biogenic emissions in the value chain are reported as -4,780.
Report Date: 4Q2024Relevance: 10%